Rising Stars: Canadian Small-Cap Stocks to Consider in June 2023

Given their long-term growth potential and attractive valuation, these three small-cap stocks could deliver multi-fold returns in the long run.

| More on:
Man holding magnifying glass over a document

Image source: Getty Images.

Given their smaller size, small-cap stocks offer higher growth prospects and can deliver superior returns in the longer run. Owing to their limited resources, however, these companies are highly susceptible to market volatility, thus making them riskier. So, investors with longer investment horizons can buy these stocks to earn superior returns. Here are three top small-cap stocks you could consider buying now.

WELL Health Technologies

WELL Health Technologies (TSX:WELL) is a digital healthcare company focusing on leveraging technology to facilitate healthcare practitioners offering virtual services. It also owns and operates an extensive network of tech-enabled outpatient healthcare clinics across Canada.

Technological advancements and increased internet penetration have led to increased adoption of telehealthcare services, thus creating multi-year growth potential for the company. Meanwhile, the company has invested in AI (artificial intelligence) technology to develop new products and enhancements, which could improve patients’ experience. Amid its growth initiatives and continued acquisitions, WELL Health’s management has provided impressive 2023 guidance. The guidance projects revenue and adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) to grow by over 21% and 10%, respectively.

Meanwhile, WELL Health has witnessed solid buying this year, with its stock price rising by over 90%. Its solid quarterly performances appear to have increased investors’ confidence, driving its stock price higher. Despite the surge, its NTM (next 12 months) price-to-sales multiple stands at 1.8, making it an attractive buy.

Savaria

Savaria (TSX:SIS) is another worthy small-cap stock to have in your portfolio due to its impressive performance and healthy growth initiatives. Last month, it reported a solid first-quarter performance. Its topline grew 15.3% to $211.6 million driven by strong organic growth of 13.5%. Its accessibility and patient care segments reported impressive gains, while its adapted vehicles segment witnessed a marginal decline of 0.8%, impacted by unfavourable currency translation.

Also, its gross margin expanded by 2.1% to 34%, thus driving its net profits. For the quarter, the company posted an adjusted EPS (earnings per share) of $0.13, representing a 30% increase from its previous year’s quarter. Further, the company’s management projects revenue growth of 8-10% for this year amid rising demand, cross-selling initiatives, and higher backlog levels. Additionally, management hopes to reach revenue of $1 billion by the end of 2025. So, its growth prospects look healthy.

Savaria pays a monthly dividend of $0.0433/share, translating into a forward yield of 3.03%. Its valuation also looks attractive, with its NTM price-to-sales multiple at 1.3.

Jamieson Wellness

Jamieson Wellness (TSX:JWEL), which manufactures, markets, and distributes natural health products across 45 countries, would be my final pick. Over the previous five years, the company has returned over 70% at a CAGR (compounded annual growth rate) of 11.2%. Healthy financials and strategic acquisitions have driven its stock price. Since 2018, the company’s revenue and EPS have grown at a 12.7% and 16.2% CAGR, respectively.

I expect the uptrend in Jamieson Wellness’ financials to continue, given its focus on product expansion, strengthening of its distribution channels, and e-commerce growth. The company’s management projects its 2023 revenue to grow by 22-28%, while its adjusted EPS could increase by 5-11%. It also pays a quarterly dividend of $0.17/share, with its forward yield currently at 2.2%.

Meanwhile, the company has been under pressure this year, losing over 14% of its stock value. Amid the pullback, JWEL trades at an NTM price-to-earnings multiple of 18.1, making it an excellent long-term buy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.  

More on Investing

man is enthralled with a movie in a theater
Dividend Stocks

What Canadians Can Expect From CPP Benefits at Ages 60 and 65 in 2024

The CPP’s standard retirement age is 65, although eligible pensioners can start payments at 60 but at a reduced benefit.

Read more »

Dividend Stocks

Lock In a 7 Percent Dividend Yield With This Royalty Stock

Given its high yield, attractive valuation, and healthy growth prospects, PZA would be an excellent royalty stock to have in…

Read more »

stocks climbing green bull market
Dividend Stocks

TFSA Dividend Investors: 3 Rock-Solid Dividend Payers Yielding up to 7%

These stocks have great track records of dividend growth.

Read more »

work from home
Stocks for Beginners

2 TSX Stocks That Could Secure Your Future

These two TSX stocks may be some of the best long-term buys today for investors looking for safety, security, and…

Read more »

A worker overlooks an oil refinery plant.
Energy Stocks

The Ultimate Energy Stock to Buy With $500 Right Now

Do you want to invest in the ultimate energy stock but only have $500? Here's one stock that can set…

Read more »

Young woman sat at laptop by a window
Dividend Stocks

5% Dividend Yield: Why I Will Be Buying and Holding This TSX Stock for Decades!

Stability and a healthy return potential are among the hallmarks of the so-called “forever stocks.” But while many stocks promise…

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Stocks for Beginners

Maximize Your $7,000 TFSA Limit in 2024 

The 2024 TFSA limit is $7,000, the highest since the 2015 limit of $10,000. You could maximize this limit by…

Read more »

thinking
Stock Market

Is Brookfield Business Partners a Buy in 2024?

Down 20% from all-time highs, Brookfield Business Partners is a cheap TSX stock that should be on top of your…

Read more »